Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trialsLancet-Martens, dr. F.M.A.C.; Kuijper, dr. A.F.M.-REDUCE-it-ASCVD
Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial InfarctionJACC-Martens, dr. F.M.A.C.-REDUCE-it-ASCVD
Cardiovascular Risk Reduction with Icosapent Ethyl for HypertriglyceridemiaNEJM-REDUCE-it-ASCVD